Jeffrey H. Buchalter
2010
In 2010, Jeffrey H. Buchalter earned a total compensation of $4.1M as Former President and Chief Executive Officer at Enzon Pharmaceuticals, a 208% increase compared to previous year.
Compensation breakdown
| Salary | $147,981 |
|---|---|
| Stock Awards | $375,001 |
| Other | $3,569,550 |
| Total | $4,092,532 |
Buchalter received $3.6M in other compensation, accounting for 87% of the total pay in 2010.
Buchalter also received $148K in salary and $375K in stock awards.
Rankings
In 2010, Jeffrey H. Buchalter's compensation ranked 1,350th out of 10,439 executives tracked by ExecPay. In other words, Buchalter earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,350 out of 10,439 | 87th |
Division Manufacturing | 483 out of 3,838 | 87th |
Major group Chemicals And Allied Products | 103 out of 921 | 89th |
Industry group Drugs | 58 out of 680 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 8 out of 142 | 94th |
Source: SEC filing on April 8, 2011.
Buchalter's colleagues
We found five more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2010.
2010
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2010
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2010
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2010
Mark Ogden
Enzon Pharmaceuticals
Acting Vice President, Finance and Principal Financial Officer
2010
Craig Tooman
Enzon Pharmaceuticals